Pre-phototherapy total serum bilirubin levels in extremely preterm infants
- PMID: 35523883
- DOI: 10.1038/s41390-022-02065-0
Pre-phototherapy total serum bilirubin levels in extremely preterm infants
Abstract
Background: Extremely preterm infants are prone to hyperbilirubinemia and its sequelae. Currently recommended thresholds for initiating phototherapy in these newborns are consensus-based (CB).
Methods: A multi-site retrospective cohort study of 642 infants born at 240/7 to 286/7 weeks' gestation, between January 2013 and June 2017, was conducted at three NICUs in Canada. Pre-phototherapy TSB percentile levels at 24 h of age were generated and contrasted with published CB thresholds.
Results: Among infants born 240/7 to 256/7 weeks' gestation, the differences between our TSB percentiles vs. the CB threshold of 85.0 µmol/L were 10.0 µmol/L (95% CI, 6.0-16.0) at the 75th percentile and 35.3 µmol/L (95% CI, 26.1-42.8) at the 95th percentile. Respectively, among infants born at 260/7 to 276/7 weeks, differences were 19.4 µmol/L (95% CI, 16.8-23.4) and 43.3 µmol/L (95% CI, 34.7-46.9). Born at 280/7 to 286/7 weeks' gestation, differences between our 75th and 95th TSB percentiles and the CB threshold of 103 µmol/L were 6.9 µmol/L (95% CI, 3.2-12.0) and 36.0 µmol/L (95% CI, 31.0-44.3), respectively.
Conclusions: We provide statistically derived pre-phototherapy TSB levels that may clarify patterns of pre-phototherapy TSB levels in extremely preterm infants.
Impact: We present statistically derived pre-phototherapy total serum bilirubin levels in a cohort of extremely preterm infants. Most of these preterm infants received phototherapy-some at below currently published thresholds. There are notable differences between our statistically derived pre-phototherapy TSB levels and currently published lower limit TSB thresholds for phototherapy. Our study results assist in the understanding of pre-phototherapy TSB levels in extremely preterm infants.
© 2022. The Author(s), under exclusive licence to the International Pediatric Research Foundation, Inc.
References
-
- Bhutani, V. K., Wong, R. J. & Stevenson, D. K. Hyperbilirubinemia in preterm neonates. Clin. Perinatol. 43, 215–232 (2016). - DOI
-
- Karimzadeh, P. et al. Bilirubin induced encephalopathy. Iran. J. Child Neurol. 14, 7–19 (2020).
-
- Olds, C. & Oghalai, J. S. Bilirubin-induced audiologic injury in preterm infants. Clin. Perinatol. 43, 313–323 (2016). - DOI
-
- Bhutani, V. K. & Wong, R. J. Bilirubin neurotoxicity in preterm infants: risk and prevention. J. Clin. Neonatol. 2, 61–69 (2013). - DOI
-
- Hulzebos, C. V., van Dommelen, P., Verkerk, P. H., Dijk, P. H. & Van Straaten, H. L. Evaluation of treatment thresholds for unconjugated hyperbilirubinemia in preterm infants: effects on serum bilirubin and on hearing loss? PLoS ONE 8, e62858 (2013). - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
